INJAK 5 TABLET Tablet

INJAK 5 TABLET সম্পর্কে

বাংলাদেশে INJAK 5 TABLET ট্যাবলেট হিসেবে পাওয়া যায়; এতে Tofacitinib আছে (৫ mg)। Tofacitinib-এর অন্য ব্র্যান্ডগুলো এই পাতায় কম দাম থেকে সাজানো আছে, দাম তুলনা করতে পারবেন। এটি তৈরি করে The ACME Laboratories Ltd। ডাক্তারের প্রেসক্রিপশন মেনে চলুন এবং অন্য ব্র্যান্ড খাওয়া যাবে কি না তা ফার্মাসিস্টের কাছ থেকে জেনে নিন।

Tofacitinib-এর ১৩টি ব্র্যান্ড বাংলাদেশে তালিকাভুক্ত। সবচেয়ে কম দাম Tofacit 5 mg Tablet-এর, প্রতি ইউনিট ৳ ৩০.০০।

INJAK 5 TABLET কী?

Made by The ACME Laboratories Ltd., INJAK 5 TABLET is a tablet whose active ingredient is Tofacitinib. The body's immune system uses signalling pathways to drive inflammation, and Tofacitinib interferes with that process. Tofacitinib belongs to a group of medicines called immunosuppressants. Ask your doctor or pharmacist if you are unsure about it.

INJAK 5 TABLET-এর ব্যবহার

It is not a painkiller for everyday aches, and it should not be started without a doctor's assessment. It is an immunosuppressant medicine, so it is meant for people whose condition has been assessed by a doctor. INJAK 5 TABLET is used for adults with moderately to severely active rheumatoid arthritis whose earlier treatment with methotrexate did not work well enough or was not tolerated. Your doctor will decide if this medicine is suitable for you.

INJAK 5 TABLET কীভাবে ব্যবহার করবেন

INJAK 5 TABLET 5 mg tablet is taken by mouth. Swallow the tablet with water. Shake the bottle well before each use. The dose and course are decided by your doctor based on your condition and other medicines you take. If you miss a dose, ask your doctor or pharmacist what to do.

INJAK 5 TABLET-এর পার্শ্বপ্রতিক্রিয়া

Common side effects reported during the first three months of treatment include upper respiratory tract infections, headache, diarrhea, and nasopharyngitis. Ask the doctor or pharmacist about anything you notice. Tell your doctor promptly about fever, persistent cough, or any sign of infection. Tell your doctor right away if you develop signs of infection such as fever, cough, or persistent sore throat.

সতর্কতা ও নিরাপত্তা

It is used with caution in people who may be at increased risk of gastrointestinal perforation. It is not known whether Tofacitinib passes into human milk, so breastfeeding decisions need medical advice. Your doctor may monitor your blood counts, liver enzymes, and lipids. Tell your doctor about infections, kidney or liver problems, pregnancy, planning pregnancy or breastfeeding before starting.

সাধারণ প্রশ্ন

What is INJAK 5 TABLET used for?

It is not a painkiller for everyday aches, and it should not be started without a doctor's assessment. It is an immunosuppressant medicine, so it is meant for people whose condition has been assessed by a doctor.

How is INJAK 5 TABLET used?

INJAK 5 TABLET 5 mg tablet is taken by mouth. Swallow the tablet with water.

Can INJAK 5 TABLET cause side effects?

Common side effects reported during the first three months of treatment include upper respiratory tract infections, headache, diarrhea, and nasopharyngitis. Ask the doctor or pharmacist about anything you notice.

Who should be careful with INJAK 5 TABLET?

It is used with caution in people who may be at increased risk of gastrointestinal perforation. It is not known whether Tofacitinib passes into human milk, so breastfeeding decisions need medical advice.

নির্দেশনা

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Rheumatoid Arthritis: Tofacitinib is indicated for the treatment of adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate response or intolerance to methotrexate. It may be used as monotherapy or in combination with methotrexate or other nonbiologic ... Read moreRheumatoid Arthritis: Tofacitinib is indicated for the treatment of adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate response or intolerance to methotrexate. It may be used as monotherapy or in combination with methotrexate or other nonbiologic disease-modifying antirheumatic drugs (DMARDs).

Psoriatic Arthritis: Tofacitinib is indicated for the treatment of adult patients with active psoriatic arthritis who have had an inadequate response or intolerance to methotrexate or other disease-modifying antirheumatic drugs (DMARDs).

Ulcerative Colitis: Tofacitinib is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis (UC).

ফার্মাকোলজি

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Rheumatoid arthritis is an autoimmune disease characterized by a dysregulation of pro-inflammatory cytokines including IL7, IL15, IL21, IL6, IFN-alpha, and IFN-beta. (3) Cytokines signalling results in tissue inflammation and joint damage by stimulating the recruitment and activation of immune cells via the janus kinase signalling pathway.

Tofacitinib is a partial and reversible janus kinase (JAK) inihibitor that will prevent the body from responding to cytokine signals. By inhibiting JAKs, tofacitinib prevents the phosphorylation and activation of STATs. The JAK-STAT signalling pathway is involved in the transcription of cells involved in hematopoiesis, and immune cell function. Tofacitinib works therapeutically by inhibiting the JAK-STAT pathway to decrease the inflammatory response. However, there is evidence to suggest that it may also achieve efficacy via other pathways as well.

মাত্রা ও সেবনবিধি

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Rheumatoid Arthritis: Tofacitinib 5 mg twice daily or Tofacitinib 11 mg once daily. Recommended dosage in patients with moderate and severe renal impairment or moderate hepatic impairment is Tofacitinib 5 mg once daily.

Psoriatic Arthritis (in combination with nonbiologic DMARDs): Tofacitinib 5 mg twice daily or Tofacitinib 11 mg once daily.  Recommended dosage in patients with moderate and severe renal impairment or moderate hepatic impairment is Tofacitinib 5 mg once daily.

Ulcerative Colitis: Tofacitinib 10 mg twice daily for at least 8 weeks; then 5 or 10 mg twice daily. Discontinue after 16 weeks of 10 mg twice daily, if adequate therapeutic benefit is not achieved. Use the lowest effective dose to maintain response.

ঔষধের মিথষ্ক্রিয়া

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

  • Potent inhibitors of Cytochrome P450 3A4 (CYP3A4) (e.g., Ketoconazole)
  • Recommended dose is Tofacitinib 5 mg once daily: One or more concomitant medications that result in both moderate inhibition of CYP3A4 and potent inhibition of CYP2C19 (e.g., fluconazole)
  • Recommended dose is Tofacitinib 5 mg once daily Potent CYP inducers (e.g.Rifampin): May result in loss of or reduced clinical response.

পার্শ্ব প্রতিক্রিয়া

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

The most commonly reported adverse reactions during the first 3 months in controlled clinical trials (occurring in greater than or equal to 2% of patients treated with Tofacitinib monotherapy or in combination with DMARDs) were upper respiratory tract infections, headache, diarrhea and nasopharyngitis.

গর্ভাবস্থায় ও স্তন্যদানকালে

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Pregnancy Category C. There are no adequate and well controlled studies in pregnant women. Tofacitinib should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.

It is not known whether Tofacitinib is excreted in human milk. Because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants from Tofacitinib, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug for the mother

সতর্কতা

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

  • Serious Infections: Avoid use of Tofacitinib during an active serious infection, including localized infections. 
  • Gastrointestinal Perforations: Use with caution in patients that may be at increased risk.
  • Laboratory Monitoring: Recommended due to potential changes in lymphocytes, neutrophils, hemoglobin, liver enzymes and lipids.
  • Immunizations: Live vaccines: Avoid use with Tofacitinib.
  • Do not initiate Tofacitinib if absolute lymphocyte count <500 cells/mm3, an absolute neutrophil count (ANC) <1000 cells/mm3 or hemoglobin <9 gm/dL.

সংরক্ষণ

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Store below 30°C. Protect from light & moisture. Keep all medicines out of the reach of children.

বিকল্প ব্র্যান্ড: Tofacitinib

একই জেনেরিকের অন্য ব্র্যান্ড, কম দাম আগে।

Tofacit Tablet

5 mg

Tofacitinib

Delta Pharma Limited

৳ ২৯.৪ ৳ ৩০.০০ ২% ছাড় প্রতি ইউনিট

Tofanib Tablet

5 mg

Tofacitinib

Globe Pharmaceuticals Ltd.

৳ ৪৭.০৪ ৳ ৪৮.০০ ২% ছাড় প্রতি ইউনিট

Tofacit XR Xr Tablet

11 mg

Tofacitinib

Delta Pharma Limited

৳ ৫৮.৮ ৳ ৬০.০০ ২% ছাড় প্রতি ইউনিট

Tofanib XR Xr Tablet

11 mg

Tofacitinib

Globe Pharmaceuticals Ltd.

৳ ৭৮.৪ ৳ ৮০.০০ ২% ছাড় প্রতি ইউনিট

Tofu Tablet

5 mg

Tofacitinib

Chemist Laboratories Ltd.

দাম দেওয়া নেই

Xelnib 5 Tablet

5 mg

Tofacitinib

Opsonin Pharma Limited

দাম দেওয়া নেই

ঔষধের তথ্য শুধু জানার জন্য, এটি চিকিৎসা পরামর্শ নয়। সবসময় ডাক্তারের প্রেসক্রিপশন মানুন এবং ফার্মাসিস্টের সাথে কথা বলুন।